Загрузка...
Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer
BACKGROUND: Molecular characterization of prostate cancer (PCa) has revealed distinct subclasses based on underlying genomic alterations occurring early in the natural history of the disease. However, how these early alterations influence subsequent molecular events and the course of the disease ove...
Сохранить в:
| Опубликовано в: : | J Clin Invest |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Clinical Investigation
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8121518/ https://ncbi.nlm.nih.gov/pubmed/33998599 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI147878 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|